Danaher Co. (NYSE:DHR) is Cortland Associates Inc. MO's 9th Largest Position

Cortland Associates Inc. MO trimmed its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 1.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 171,882 shares of the conglomerate's stock after selling 1,841 shares during the quarter. Danaher accounts for approximately 4.5% of Cortland Associates Inc. MO's investment portfolio, making the stock its 9th biggest position. Cortland Associates Inc. MO's holdings in Danaher were worth $39,455,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Baader Bank Aktiengesellschaft increased its position in shares of Danaher by 1.1% during the fourth quarter. Baader Bank Aktiengesellschaft now owns 44,723 shares of the conglomerate's stock worth $10,266,000 after acquiring an additional 470 shares during the period. Defender Capital LLC. grew its stake in Danaher by 4.4% during the 4th quarter. Defender Capital LLC. now owns 137,951 shares of the conglomerate's stock worth $31,667,000 after purchasing an additional 5,866 shares in the last quarter. Ibex Wealth Advisors purchased a new stake in Danaher during the 4th quarter worth about $2,715,000. Hantz Financial Services Inc. raised its position in Danaher by 37.7% in the 4th quarter. Hantz Financial Services Inc. now owns 17,210 shares of the conglomerate's stock valued at $3,951,000 after purchasing an additional 4,710 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. boosted its stake in shares of Danaher by 0.6% in the 4th quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate's stock valued at $382,936,000 after buying an additional 9,942 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

DHR traded down $0.68 on Thursday, hitting $223.05. 4,765,436 shares of the company traded hands, compared to its average volume of 3,510,213. The company has a 50 day moving average of $235.89 and a 200-day moving average of $253.45. Danaher Co. has a 12-month low of $221.34 and a 12-month high of $281.70. The stock has a market capitalization of $161.11 billion, a PE ratio of 42.68, a PEG ratio of 4.43 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same quarter in the prior year, the firm earned $2.09 earnings per share. Sell-side analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. Danaher's dividend payout ratio (DPR) is presently 20.61%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. UBS Group cut their target price on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research note on Wednesday, October 23rd. TD Cowen increased their price objective on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Citigroup decreased their price objective on shares of Danaher from $305.00 to $285.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Robert W. Baird dropped their target price on Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a report on Tuesday. Finally, Jefferies Financial Group decreased their price target on Danaher from $285.00 to $260.00 and set a "buy" rating for the company in a report on Wednesday. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $278.95.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.